For anatomies big and small, our line of epistaxis products accommodates patients’ individual needs by offering anterior and posterior options in a range of sizes.
Epistaxis products incorporate RAPHID RHINO◊ technology, a proprietary blend of CarboxyMethyl Cellulose (CMC). This CMC-infused fabric contains self-lubricating properties that when wet take on a gel consistency for ease of insertion and removal. The ultra-low profile of our epistaxis solutions quickly conforms to anatomy, and provides a gentle, even compression to the nasal area.
- Quickly conforms to nasal anatomy
- Provides gentle and even compression to areas of epistaxis
- CMC-infused fabric is designed to prevent adherence to tissue or blood clots upon removal
- Available in a wide range of sizes
A comparison between our epistaxis solutions with RAPID RHINO technology and Rhino Rocket™1 for the treatment of epistaxis in an emergency department reveals products utilizing RAPID RHINO technology provide greater patient comfort at insertion and removal.2
Unilateral models are offered in a variety of sizes and configurations.
- RR 450 4.5cm Inflatable Unilateral without Airway
- RR 530 5.5cm Non-Inflatable Rapid-PacTM
- RR 550 5.5cm Inflatable Unilateral without Airway
- RR 551 5.5cm Inflatable Unilateral with Airway
- RR 750 7.5cm Inflatable Unilateral without Airway
- RR 751 7.5cm Inflatable Unilateral with Airway
- RR 900 9cm Inflatable Dual Balloon
Bilateral models are offered in two sizes, 5.5cm and 7.5cm with and without an airway.
- RR 552 5.5cm Inflatable Bilateral Epistaxis Device
- RR 555 5.5cm Inflatable Bilateral Epistaxis Device with Airway
- RR 752 7.5cm Inflatable Bilateral Epistaxis Device
- RR 755 7.5cm Inflatable Bilateral Epistaxis Device with Airway
1. Rhino Rocket is a registered trademark of Shippert Medical Technologies Corp. and is used for reference purposes only.
2. Singer AJ, Blanda M, Cronin K, LoGiudice-Khwaja M, Gulla J, Bradshaw J, Katz. A Comparison of nasal tampons for the treatment of epistaxis in the emergency department: a randomized controlled trial. Ann Emerg Med. 2005; 45:134–139